TAFA4 and cervical cancer: Due to more than 70% of cervical cancer was caused by HPV16/18 [28], a higher proportion of cervical cancer was in HPV16/18 group, which led to FAM19A4 methylation differences between HPV16/18 and 12 other hrHPV groups from the all sample.